A methodology for the analysis of PSA response signatures

- Ebert, Martin A., Lamb, David S., Joseph, David J., Steigler, Allison, Denham, James W.

A phantom assessment of achievable contouring concordance across multiple treatment planning systems

- Pogson, Elise M., Begg, Jarrad, Jameson, Michael G., Dempsey, Claire, Latty, Drew, Batumalai, Vikneswary, Lim, Andrew, Kandasamy, Kankean, Metcalfe, Peter E., Holloway, Lois C.

A prospective, multi-centre trial of multi-parametric MRI as a biomarker in anal carcinoma

- Jones, Michael, Hruby, George, Holder, Carl, Oldmeadow, Christopher, Martin, Jarad, Coolens, Catherine, Driscoll, Brandon, Stanwell, Peter, Kumar, Mahesh, Capp, Anne, Sridharan, Swetha, Arm, Jameen, Gallagher, Sarah

A virtual dosimetry audit - towards transferability of gamma index analysis between clinical trial QA groups

- Hussein, Mohammad, Clementel, Enrico, Nakamura, Mitsuhiro, Hurkmans, Coen, Clark, Catherine H., Global Quality Assurance of Radiation Therapy Clinical Trial Harmonisation Group,, Eaton, David J., Greer, Peter B., Haworth, Annette, Ishikura, Satoshi, Kry, Stephen F., Lehmann, Joerg, Lye, Jessica, Monti, Angelo F.

Analysis of cardiac substructure dose in a large, multi-centre danish breast cancer cohort (the DBCG HYPO trial): Trends and predictive modelling

- Finnegan, Robert, Lorenzen, Ebbe Laugaard, Dowling, Jason, Jensen, Ingelise, Berg, Martin, Thomsen, Mette Skovhus, Delaney, Geoff P., Koh, Eng-Siew, Thwaites, David, Brink, Carsten, Offersen, Birgitte Vrou, Holloway, Lois

Association between treatment planning and delivery factors and disease progression in prostate cancer radiotherapy: Results from the TROG 03.04 RADAR trial

- Marcello, Marco, Ebert, Martin, Haworth, Annette, Steigler, Allison, Kennedy, Angel, Joseph, David, Denham, James

Assuring high quality treatment delivery in clinical trials: results from the Trans-Tasman Radiation Oncology Group (TROG) study 03.04 "RADAR" set-up accuracy study

- Haworth, Annette, Kearvell, Rachel, Greer, Peter B., Hooton, Ben, Denham, James W., Lamb, David, Duchesne, Gillian, Murray, Judy, Joseph, David

Correlation of 3D-planned and measured dosimetry of photon and electron craniospinal radiation in a pediatric anthropomorphic phantom

- Hood, Claire, Kron, Tomas, Hamilton, Chris, Callan, Scott, Howlett, Steve, Alvaro, F., Back, M.

Does the planning dose-volume histogram represent treatment doses in image-guided prostate radiation therapy?: assessment with cone-beam computerised tomography scans

- Hatton, Joan A., Greer, Peter B., Tang, Colin, Wright, Philip, Capp, Anne, Gupta, Sanjiv, Parker, Joel, Wratten, Chris, Denham, James W.

Dosimetry, clinical factors and medication intake influencing urinary symptoms after prostate radiotherapy: an analysis of data from the RADAR prostate radiotherapy trial

- Yahya, Noorazul, Ebert, Martin A., Bulsara, Max, Haworth, Annette, Kennedy, Angel, Joseph, David J., Denham, Jim W.

Intensity-based dual model method for generation of synthetic CT images from standard T2-weighted MR images - generalized technique for four different MR scanners

- Koivula, Lauri, Kapanen, Mika, Korhonen, Juha, Seppälä, Tiina, Collan, Juhani, Dowling, Jason A., Greer, Peter B., Gustafsson, Christian, Gunnlaugsson, Adalsteinn, Olsson, Lars E., Wee, Leonard

International comparison of cosmetic outcomes of breast conserving surgery and radiation therapy for women with ductal carcinoma in situ of the breast

- Olivotto, Ivo A., Link, Emma, Phillips, Claire, Whelan, Timothy J., Bryant, Guy, Kunkler, Ian H., Westenberg, A. Helen, Purohit, Kash, Ahern, Verity, Graham, Peter H., Akra, Mohamed, McArdle, Orla, Ludbrook, Joanna J., Harvey, Jennifer A., Maduro, John H., Kirkove, Carine, Gruber, Guenther, Martin, Joseph D., Campbell, Ian D., Delaney, Geoff P., Chua, Boon H.

Is there more than one proctitis syndrome? A revisitation using data from the TROG 96.01 trial

- Capp, Anne, Inostroza-Ponta, Mario, Atkinson, Chris, North, John, Poulsen, Michael, Spry, Nigel A., Tai, Keen-Hun, Wynne, Chris, Duchesne, Gillian, Steigler, Allison, Denham, James W., Bill, Dana, Moscato, Pablo, Lai, Chi, Christie, David, Lamb, David, Turner, Sandra, Joseph, David, Matthews, John

MRI-guided prostate radiation therapy planning: investigation of dosimetric accuracy of MRI-based dose planning

- Lambert, Jonathon, Greer, Peter B., Kumar, Mahesh, Dowling, Jason, Hauville, Sarah, Hughes, Cynthia, Fisher, Kristen, Lau, Peter, Denham, James W., Salvado, Olivier, Menk, Fred, Patterson, Jackie, Parker, Joel, Dahl, Kara, Gupta, Sanjiv, Capp, Anne, Wratten, Chris, Tang, Colin

Oligometastatic bone disease in prostate cancer patients treated on the TROG 03.04 RADAR trial

- Sridharan, Swetha, Steigler, Allison, Attia, John, Holliday, Elizabeth G., Denham, James W., Spry, Nigel A., Joseph, David, Lamb, David S., Matthews, John H., Atkinson, Chris, Tai, Keen-Hun, Duchesne, Gillian, Christie, David

Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines: GHG OAR consensus contouring guidance

- Mir, Romaana, Kelly, Sarah M., Ishikura, Satoshi, Kristensen, Ingrid, Kry, Stephen F., Lehmann, Joerg, Michalski, Jeff M., Monti, Angelo F., Nakamura, Mitsuhiro, Thompson, Kenton, Yang, Huiqi, Zubizarreta, Eduardo, Xiao, Ying, Andratschke, N, Miles, E, Moore, Alisha, Clark, Catharine H., Clementel, Enrico, Corning, Coreen, Ebert, Martin, Hoskin, Peter, Hurkmans, Coen W.

Paradoxical metastatic progression following 3 months of neo-adjuvant androgen suppression in the TROG 96.01 trial for men with locally advanced prostate cancer

- Denham, James W., Steigler, Allison, Wynne, Chris, Lamb, David S., Tai, Keen-Hun, Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Turner, Sandra, North, John, Christie, David

PSA response signatures: a powerful new prognostic indicator after radiation for prostate cancer?

- Denham, James W., Lamb, David S., Joseph, David, Matthews, John, Atkinson, Chris, Spry, Nigel A., Duchesne, Gillian, Ebert, Martin, Steigler, Allison, D'Este, Catherine

Radiation dose escalation or longer androgen suppression for locally advanced prostate cancer? Data from the TROG 03.04 RADAR trial

- Denham, James W., Steigler, Allison, Tai, Keen-Hun, Gogna, Nirdosh Kumar, Gill, Suki, Tan, Hendrick, Kearvell, Rachel, Murray, Judy, Ebert, Martin, Haworth, Annette, Kennedy, Angel, Delahunt, Brett, Joseph, David, Oldmeadow, Christopher, Holliday, Elizabeth G., Attia, John, Lamb, David S., Spry, Nigel A., Duchesne, Gillian, Atkinson, Chris, Matthews, John, Turner, Sandra, Kenny, Lizbeth

Radiotherapy for node-positive prostate cancer: 2019 recommendations of the Australian and New Zealand Radiation Oncology Genito-Urinary group

- Lieng, Hester, Kneebone, Andrew, Hayden, Amy J., Christie, David R. H., Davis, Brian J., Eade, Thomas N., Emmett, Louise, Holt, Tanya, Hruby, George, Pryor, David, Sidhom, Mark, Skala, Marketa, Yaxley, John, Shakespeare, Thomas P.